Epstein-Barr virus: An important vaccine target for cancer prevention

Jeffrey I. Cohen, Anthony S. Fauci, Harold Varmus, Gary J. Nabel

Research output: Contribution to journalArticle

Abstract

Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.

Original languageEnglish (US)
Article number107fs7
JournalScience Translational Medicine
Volume3
Issue number107
DOIs
StatePublished - Nov 2 2011
Externally publishedYes

Fingerprint

Cancer Vaccines
Human Herpesvirus 4
Infectious Mononucleosis
National Institutes of Health (U.S.)
Vaccines
Biomarkers
Clinical Trials
Research
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Epstein-Barr virus : An important vaccine target for cancer prevention. / Cohen, Jeffrey I.; Fauci, Anthony S.; Varmus, Harold; Nabel, Gary J.

In: Science Translational Medicine, Vol. 3, No. 107, 107fs7, 02.11.2011.

Research output: Contribution to journalArticle

Cohen, Jeffrey I. ; Fauci, Anthony S. ; Varmus, Harold ; Nabel, Gary J. / Epstein-Barr virus : An important vaccine target for cancer prevention. In: Science Translational Medicine. 2011 ; Vol. 3, No. 107.
@article{c90e7b6f6e0f475aa76dbab39798b604,
title = "Epstein-Barr virus: An important vaccine target for cancer prevention",
abstract = "Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.",
author = "Cohen, {Jeffrey I.} and Fauci, {Anthony S.} and Harold Varmus and Nabel, {Gary J.}",
year = "2011",
month = "11",
day = "2",
doi = "10.1126/scitranslmed.3002878",
language = "English (US)",
volume = "3",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "107",

}

TY - JOUR

T1 - Epstein-Barr virus

T2 - An important vaccine target for cancer prevention

AU - Cohen, Jeffrey I.

AU - Fauci, Anthony S.

AU - Varmus, Harold

AU - Nabel, Gary J.

PY - 2011/11/2

Y1 - 2011/11/2

N2 - Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.

AB - Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.

UR - http://www.scopus.com/inward/record.url?scp=80455164859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80455164859&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.3002878

DO - 10.1126/scitranslmed.3002878

M3 - Article

C2 - 22049067

AN - SCOPUS:80455164859

VL - 3

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 107

M1 - 107fs7

ER -